CV Sciences (CVSI) SEC Filings & 10K Form $0.03 +0.00 (+8.49%) As of 04/23/2025 02:52 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Recent CV Sciences SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/15/20254:25 PMCV Sciences (Filer)Form DEF 14A03/27/20254:03 PMCV Sciences (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/27/20258:25 AMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/20/20254:27 PMCV Sciences (Issuer)McCorkle William (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/20/20254:27 PMCV Sciences (Issuer)Dowling Joseph D (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/20/20254:28 PMCV Sciences (Issuer)Grasser Joerg (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/20/20254:28 PMCorroon James Michael Jr. (Reporting)CV Sciences (Issuer)Form 4Statement of changes in beneficial ownership of securities 11/25/20243:17 PMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/21/20243:38 PMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/20248:17 AMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/13/20243:54 PMCV Sciences (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/13/20248:28 AMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/08/20246:12 PMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/24/20244:46 PMCorroon James Michael Jr. (Reporting)CV Sciences (Issuer)Form 4Statement of changes in beneficial ownership of securities 06/24/20244:48 PMCV Sciences (Issuer)McCorkle William (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/24/20244:25 PMCV Sciences (Issuer)Dowling Joseph D (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/24/20244:30 PMCV Sciences (Issuer)Grasser Joerg (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/14/20248:10 AMCV Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies LGVN SEC Filings EGRX SEC Filings FNCH SEC Filings CALC SEC Filings GRCE SEC Filings CVM SEC Filings PASG SEC Filings PULM SEC Filings PMN SEC Filings JATT SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:CVSI) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CV Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
